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Background: Heavy binge drinking is increasingly frequent among adolescents, and consumption of 3,4-
methylenedioxymethamphetamine (MDMA) is often combined with ethanol (EtOH). The long-lasting effects of
intermittent exposure to EtOH and MDMA during adolescence on learning and memory were evaluated in adult
mice using the Hebb-Williams maze.
Methods: Adolescent OF1 mice were exposed to EtOH (1.25 g/kg) on two consecutive days at 48-h intervals over a
14-day period (from PD 29 to 42). MDMA (10 or 20 mg/kg) was injected twice daily at 4-h intervals over two
consecutive days, and this schedule was repeated six days later (PD 33, 34, 41 and 42), resulting in a total of eight
injections. Animals were initiated in the Hebb-Williams maze on PND 64. The concentration of brain monoamines
in the striatum and hippocampus was then measured.
Results: At the doses employed, both EtOH and MDMA, administered alone or together, impaired learning in the
Hebb-Williams maze, as treated animals required more time to reach the goal than their saline-treated counterparts.
The groups treated during adolescence with EtOH, alone or plus MDMA, also presented longer latency scores and
needed more trials to reach the acquisition criterion score. MDMA induced a decrease in striatal DA concentration,
an effect that was augmented by the co-administration of EtOH. All the treatment groups displayed an imbalance
in the interaction DA/serotonin.
Conclusions: The present findings indicate that the developing brain is highly vulnerable to the damaging effects
of EtOH and/or MDMA, since mice receiving these drugs in a binge pattern during adolescence exhibit impaired
learning and memory in adulthood.
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MDMA (3,4-methylenedioxymethamphetamine) users also
consume ethanol frequently (EtOH) [1,2]. For example, [3]
reported that 85% of those attending rave parties con-
sumed both EtOH and MDMA. Similarly, heavy binge
drinking is becoming increasingly common among teen-
agers in the USA and Europe [4–6]. In a survey of Spanish
adolescents, 49.6% of those who had consumed alcohol in
the previous month reported getting drunk during binges.
Among those who consumed ecstasy, 98% admitted taking* Correspondence: marta.rodriguez@uv.es
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reproduction in any medium, provided the orit with alcohol. Similarly, use of ecstasy is more common
among adolescents who drink alcohol (2.5%) [7]. Research
with human adolescents has provided clear evidence that
alcohol abuse during the teenage years has deleterious
effects, with alcohol-related problems and neurological def-
icits being more prevalent among adolescents that abuse
alcohol [5,8].
EtOH is an allosteric modulator of many transmem-
brane receptors [9]. Functionally, it acts primarily as a
CNS depressant, potentiating the action of GABA at the
GABAA receptor [10]. MDMA, on the other hand, causes
a rapid efflux of dopamine (DA) and serotonin (5-HT) in
several brain areas immediately after it is administered, in-
cluding the striatum and nucleus accumbens (NAc), [11].ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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MDMA interactions in animal models [12–15], and the
studies undertaken have been characterized by a great in-
consistency in the treatment schedules employed and the
time at which measurements were taken. EtOH has been
shown to increase blood concentrations of MDMA, and
more intensely in the striatum and cortex than in the
hippocampus [16]. On the other hand, levels of alcohol
dehydrogenase 2, which metabolizes EtOH to acetalde-
hyde, have been found to be 35% lower in MDMA-treated
rats than in controls [17].
EtOH modifies many of the effects of MDMA, and
studies suggest that the interaction between the two
drugs depends on the dose, administration regimen and
ambient temperature in question [18,19]. Few studies to
date have evaluated chronic exposure to both EtOH and
MDMA. In recent experiments, we have observed that
MDMA administration during adolescence induces a
specific behavioral and neurochemical profile in adult
animals when combined with a pattern of EtOH admin-
istration that models binge drinking. This is evidence
that the interaction of these two drugs in the adolescent
brain produces lasting effects [20]. In addition, exposure
to MDMA during adolescence increased the anxyogenic
response and decreased concentrations of DA in the stri-
atum. EtOH increased these effects while undermining
the hyperthermic response induced by MDMA. In the
study in question, passive avoidance was affected only
when EtOH was administered alone.
Clinical and experimental studies have provided evi-
dence of the special sensitivity of the adolescent brain to
some effects of EtOH, such as memory impairment [21]
and EtOH-induced brain damage [22]. Adolescents are
less sensitive to EtOH-induced motor impairments [23]
and loss of righting reflex [24] but are more sensitive to
EtOH-induced hypothermia [25] and hippocampal-
dependent memory impairments [26], although the op-
posite effect has also been reported [27,28]. A possible
explanation for these discrepant results is that adoles-
cents learn the spatial Morris water maze task more
slowly than adults, although EtOH is thought to impair
spatial memory in both age groups [29]. We have
previously observed that intermittent administration of
EtOH during adolescence enhances neural cell death in
several brain regions (neocortex, hippocampus and
cerebellum) and produces long-lasting neurobehavioral
impairments in conditional discrimination learning,
motor learning and discrimination between novel and
familiar objects [30].
Based on the abovementioned studies, we hypothe-
sized that intermittent EtOH and/or MDMA intoxica-
tion during adolescence would have long-lasting
consequences for memory and learning. The aim of the
present study was to employ the Hebb-Williams maze toinvestigate how MDMA mediates the long-term conse-
quences of exposure to EtOH during adolescence for
memory function. In order to clarify whether or not the
effects of exposure to drugs during adolescence are
related with the neurotoxic damage that they produce,
we determined the concentration of dopamine and sero-
tonin and their metabolites in the striatum and hippo-




A total of 78 male mice of the OF1 strain (CHARLES
RIVER, Barcelona, Spain) were employed in the study.
Animals were 21 days old on arrival at the laboratory
and were all housed under standard conditions in
groups of four (cage size 28 x 28 x 14.5 cm), at a constant
temperature (21+ 2°C), with a reversed light schedule
(white lights on 19:30–07:30 h) and food and water avail-
able ad libitum (except during the behavioral test). All pro-
cedures involving the mice and their care complied with
national, regional and local laws and regulations, and with
European Community Council Directives (86/609/EEC, 24
November 1986).
Drug treatment and experimental design
The doses of EtOH [20,31–33] and MDMA [34–39] were
based on those used in previous studies. Animals were
injected i.p with volumes of 0.01 ml/g MDMA (±3,4-
methylenedioxymetamphetamine hydrochloride, Labora-
torios Lipomed AG, Switzerland) and EtOH in a volume
of 0.02 ml/g. The control group was injected with physio-
logical saline (NaCl 0.9%), which was also used for dissolv-
ing the drugs. The groups receiving both EtOH and
MDMA were administered each substance in a separate
injection. The EtOH dose employed (1.25 g/kg) induced a
blood concentration of 0.9 mg/ml in OF1 adolescent mice
5 min after administration. In an adolescent human, this
dose would correspond with 33 g of EtOH, which repre-
sents two or three alcoholic drinks (taking into account
that one alcoholic drink contains 13.7 g of EtOH).
After an acclimatization period of 8 days, animals were
divided into 6 groups: two groups received physiological
saline (Sal, n = 8) or 1.25 g/kg of EtOH (E1.25, n = 8) in a
schedule in which injections were administered twice
daily (with a 4-hour interval) on two consecutive days
followed by an interval of two “drug-free” days, over a
two-week period (a total of 16 doses). Another two
groups received 10 or 20 mg/kg of MDMA (M10, n = 8;
M20, n = 8) in a pattern in which injections were given
twice daily (with a 4 hour interval) on two consecutive
days, with an interval of six days without injections, over
a two-week period (a total of 8 doses). The last two
groups received 1.25 g/kg of EtOH and 10 or 20 mg/kg
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schedule in which adolescent animals were injected
twice daily with EtOH on PND 29, 30, 37 and 38 and
with EtOH plus MDMA on PND 33, 34, 41 and 42. Be-
havioral tests were performed three weeks after treat-
ment had finalized (PND 64 to 75). In this way, each
mouse received eight drug administrations that simu-
lated a binge pattern characteristic of that seen in human
adolescents and young adults [40]. A more detailed de-
scription of the experimental procedure is presented in
Table 1.
Procedure and apparatus
The maze we used in our experiments is made of black
plastic and is 60 cm wide × 60 cm long × 10 cm high. It
contains a start box and a goal box (both 14 cm wide ×
9 cm long) which are positioned at diagonally opposite
corners. The maze contains cold water at a wading
depth (15°C, 3.5 cm high), while the goal box is stocked
with fresh dry tissue. Several maze designs are produced
by fixing different arrangements of barriers to a clear
plastic ceiling. This apparatus allows the cognitive
process of routed learning and the motivation of water
escape to be measured.
The procedure we followed was based on that employed
by Galsworthy et al. [41], in which mice must navigate the
maze and cross from the wet start box to the dry goal box
in order to escape the cold water. Animals underwent a 5-
min habituation period (dry sand, no barriers) on day 1
and undertook problem A on day 2 and problem D on
day 3 (4 trials/day) (practice mazes). Mice were subse-
quently submitted to mazes 1, 5, 3, 4 and 8 on separate
days on which 8 trials took place (see [42] for all maze
designs). The time limit for reaching the goal box was
5 min, after which the mouse was guided to the box. The
following measurements were recorded: acquisition criter-
ion score, considered to be completion of the task in less
than 60 s in two consecutive sessions; total latency score
(the sum of the latencies in all the problem trials in each
maze); latency for reaching the goal in the 8th trial; and
error scores, for which a similar total was used (where
“error” was considered as entering the error zone specified
by [42]).
Following the Stanford and Brown classification (2003),
the mazes were defined as easy (1, 3 and 4) or difficult (5
and 8).
Analysis of biogenic amines
A different set of animals (n=5 in each group) was exposed
to the same treatment schedule, but on the day corre-
sponding with their introduction to the maze, were sacri-
ficed by cervical fracture following a procedure similar to
that described in Daza-Losada et al. [34]. Within 2 min,
their brains were removed and placed on an ice-cold plate.The striatum and hippocampus were removed, frozen on
dry ice, and stored at −80°C. The tissue was thawed,
weighed and then homogenized in 200 μl of perchloric acid
(0.1 N) using ultrasounds. The homogenate was centri-
fuged at 14,000 rpm for 30 min. The supernatant was
divided into aliquots for the analysis of biogenic amines.
Using a high performance liquid chromatograph (Agilent
1100 series HPLC) Dopamine (DA), dihydroxyphenyl acetic
acid (DOPAC), serotonin (5-HT) and 5-hydroxyindole
acetic acid (5-HIAA) were analyzed in the striatum and 5-
HT and 5-HIAA were analyzed in the hippocampus. Sam-
ples were applied to a column (ZORBAX Eclipse XDB-C8
46 × 150 mm, 5 μm; Agilent Zorbax High Pressure
Cartridge Guard-column). A mobile phase consisting of a
800 ml solution of sodium acetate (0.01 M), a 500 ml solu-
tion of citric acid (0.01 M), ethylenediaminetetraacetic acid
disodium salt dehydrate (EDTA, 148 mg) and methanol
(255 ml) was passed through the column at a constant flow
of 1 ml/min. The HPLC was maintained at a constant
temperature (21±1°C). Analytes were oxidized on a glassy
carbon electrode maintained at 300 mV (450 mV for HVA
detection) against an Ag/AgCl reference electrode (BAS).
The complete separation of biogenic amines was achieved
in 25 min. Data were collected and analyzed using the
Merk-Hitachi software package (Model D-7000).
Statistical analysis
The data of the Hebb-Williams maze were analyzed using
an ANOVA with two “between” subject variables - Etha-
nol, with two levels (0 and 1.25 mg/kg), and MDMA, with
three levels (0, 10 and 20 mg/kg) - and one “within” sub-
ject variable- level of difficulty of the maze, with two levels
(easy and difficult). Maximum latencies were scored by
individuals unable to complete the task within the time
limit. Latency values in the Hebb Williams maze were
transformed to log scores in order to normalize the data.
An ANOVA of the latency to reach the goal and the
number of errors made during the eight trials was per-
formed with the same between variables and a within
variable - “trial”, with eight levels - for both easy and dif-
ficult mazes.
Monoamine concentration was analyzed using a mixed




The ANOVA for the mean of the total latency score
(Figure 1) revealed an effect of the variable Level of diffi-
culty [F (1,42) = 134.225; p < 0.001], as more time was
employed in the difficult mazes than in the easy ones
(p < 0.001). The interaction Maze × Ethanol × MDMA
also had a significant effect [F (2,42) = 3.256; p < 0.05]. In
the easy mazes, all the treatment groups employed more
Table 1 Experimental procedure
Groups / PND 29 30 31-32 33 34 35-36 37 38 39-40 41 42 43-63 64





mazeM10 M10/M10 M10/M10 M10/M10 M10/M10
M20 M20/M20 M20/M20 M10/M10 M10/M10
E1.25 E1.25/E1.25 E1.25/E1.25 E1.25/E1.25 E1.25/E1.25 E1.25/E1.25 E1.25/E1.25
E1.25+M10 E1.25+M10/E1.25+M10 E1.25+M10/E1.25+M10 E1.25/E1.25 E1.25/E1.25 E1.25+M10/E1.25+M10 E1.25+M10/E1.25+M10
















Figure 1 Effects of intermittent ethanol and MDMA administration during adolescence on the mean latency score in the
Hebb-Williams maze. The mazes were classified as easy (1, 3 and 4) or difficult (5 and 8). Mice were treated with Saline (Sal), 10 or 20 mg/kg of
MDMA (M10 and M20), 1.25 g/kg of ethanol (E1.25), or 1.25 g/kg of ethanol + 10 or 20 mg/kg of MDMA (E1.25 +M10 and E1.25 +M20). Data are
presented as mean values ± S.E.M. Differences with respect to the saline group * p< 0.001; with respect to the M10 group+ p< 0.001; with
respect to the E1.25 and e.125+M20 group τ p< 0.00.
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(p < 0.001 in all cases). In the difficult mazes, Saline and
M10 groups had shorter latencies than the rest of the
groups (p < 0.001). In both mazes, the M10 group
showed shorter latencies than the E1.25 and M20 groups
and both the groups receiving EtOH plus MDMA
(p < 0.001 in all cases). Moreover, longer latencies were
displayed by the groups treated with E1.25 +M10 than
those treated only with EtOH or EtOH plus M20
(P < 0.001 in both mazes).
The ANOVA for the latency to reach the goal in each
trial (Figure 2a and 2b) revealed a significant effect of the
interaction Trial × Ethanol in the easy [F (7,294) = 2.636;
p < 0.01] and difficult mazes [F (7,294) = 3.737; p < 0.001].
In the easy mazes, longer latencies were observed in the
groups treated with EtOH in all the trials but the second
(p < 0.03 for the first and third and p< 0.01 for the
remaining trials). In the difficult mazes, the groups treated
with EtOH also showed longer latencies in the fifth
(p < 0.01), sixth (p< 0.01), seventh (p < 0.04) and eighth
trials (p < 0.01). In addition, the groups that did not re-
ceive EtOH presented a significantly shorter latency in the
last trial than in the first in both types of mazes (p < 0.05
for the easy and p< 0.001 for the difficult). However,
changes were not detected in the groups treated with
EtOH.
The ANOVA for the Acquisition criterion score
(Figure 3), which represented the number of trials neces-
sary for the task to be completed in less than 60 s in two
consecutive sessions, revealed an effect of the variable
Level of difficulty [F (1,42) = 13.645; p < 0.001], as themice employed more time in the difficult mazes than the
easy ones (p < 0.001). Administration of EtOH also
showed a significant effect [F (1,42) = 6.373; p < 0.01], as
the groups treated with EtOH needed more trials to
complete the task (p < 0.01). This effect was the result of
the high number of trials necessary for the E1.25 and
E1.25 +M10 groups to meet this criterion in the easy
mazes (p < 0.03).
The ANOVA for the total number of errors revealed an
effect of the variable Level of difficulty [F (1,42) = 7.119;
p < 0.001], as a higher number of errors were observed in
the difficult mazes than in the easy ones (p < 0.001). The
ANOVA for the number of errors in each trial (Figure 4a
and 4b) showed that all the groups committed signifi-
cantly fewer errors in trials 5, 6, 7 and 8 than in trials 1, 2,
3 and 5 in both easy and difficult mazes (p < 0.001 in all
cases).
Brain monoamines
The brain monoamine data are presented in Table 2.
The ANOVA performed for the striatal levels of DA
showed a significant effect of the interaction Alcohol ×
Dose of MDMA [F (2,30) = 3.955; p < 0.03]. Lower levels
of DA were detected in the M20, E1.25 +M10 and
E1.25 +M20 groups than in the saline and M10 groups
(p < 0.001, in all cases).
Striatal DOPAC levels showed a significant effect of the
variable MDMA [F (2, 30) = 7.666; p < 0.003]. Lower levels
of this metabolite were detected in the groups treated with
20 mg/kg of MDMA (M20 and E1.25 +M20) than in the
non-MDMA treated groups (p< 0.001, in all cases).
Figure 2 Effects of intermittent ethanol and MDMA administration during adolescence on latency to reach the goal on each trail in
the Hebb-Williams maze (2a for the easy and 2b for the difficult mazes). The mazes were classified as easy (1, 3 and 4) or difficult (5 and 8).
Mice were treated with Saline (Sal), 10 or 20 mg/kg of MDMA (M10 and M20), 1.25 g/kg of ethanol (E1.25), or 1.25 g/kg of ethanol + 10 or 20 mg/
kg of MDMA (E1.25 +M10 and E1.25 +M20). Data are presented as mean values ± S.E.M. Differences with respect to the first trial * p < 0.05 in the
easy and 0.001 in the difficult.
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action Alcohol ×Dose of MDMA [F (2,30) = 5.507;
p < 0.01], with a decrease being observed in the groups
treated only with EtOH (p < 0.05) or 10 mg/kg of
MDMA (p < 0.02).
The concentrations of striatal [F (1,30) = 4.777; p < 0.03]
and hippocampal [F (2,30) = 5.215; p < 0.03] serotonin
showed an effect of the variable Alcohol with higher levels
of this monoamine being detected in animals treated with
EtOH (E1.25, E1.25 +M10 and E1.25+M20).Discussion
This is the first study to address the long-lasting effects
of intermittent administration of EtOH plus MDMA
during adolescence on learning and memory in adult
mice. Our results confirm that the adolescent brain is
highly sensitive to the administration of EtOH and/or
MDMA and that the effects of these drugs are mani-
fested in adulthood. Exposure to EtOH or MDMA dur-
ing adolescence, either separately or together, impaired
learning in the Hebb-Williams maze. All the treatment
Figure 3 Effects of intermittent ethanol and MDMA administration during adolescence on the acquisition criterion score in the
Hebb-Williams maze. The mazes were classified as easy (1, 3 and 4) or difficult (5 and 8). Mice were treated with Saline (Sal), 10 or 20 mg/kg of
MDMA (M10 and M20), 1.25 g/kg of ethanol (E1.25), or 1.25 g/kg of ethanol + 10 or 20 mg/kg of MDMA (E1.25 +M10 and E1.25 +M20). The
acquisition criterion score is considered to be the completion of the task in less than 60 s in two consecutive sessions. Data are presented as
mean values ± S.E.M. Differences with respect to the non-ethanol-treated groups ** p < 0.01.
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trols. In addition, animals treated with EtOH presented
longer latencies in the last four trials and did not show a
reduction in the time needed to reach the goal in con-
secutive trials, unlike the groups treated with saline or
MDMA alone. The groups treated with EtOH also
required more trials to reach the acquisition criterion
score. These results highlight that ethanol impairs the
development of learning regardless of whether or not
MDMA is also administered. However, a progressive re-
duction in the number of errors committed in successive
trials was observed in all the groups, in both easy and
difficult mazes. On the other hand, monoamine levels
were significantly affected by treatment during adoles-
cence, with a significant decrease of striatal DA being
observed in the groups treated with 20 mg/kg of
MDMA, alone or plus EtOH and in the groups treated
with 10 mg/kg of MDMA plus EtOH, thus confirming
that EtOH increases the neurotoxic effect of MDMA in
mice.
The Hebb-Williams maze is a complex spatial learning
test that is frequently used to detect changes in cognitive
functions [43], such as those brought about by environ-
mental enrichment [44]. One of the advantages of this
test is that the mazes vary in difficulty, so that animals
with learning disabilities perform more poorly as the
tasks become more difficult. The five mazes employed in
the present work were chosen on the basis of their vary-
ing levels of difficulty. Mazes 1, 3 and 4 are generallyconsidered to be easy, while mazes 5 and 8 are consid-
ered to be difficult [45], although maze 5 has also been
classified as intermediate [46]. The time needed for the
animals to reach the goal or the acquisition criterion
score and the number of errors was significantly higher
in the difficult mazes than in the easy mazes, thus con-
firming their varying levels of difficulty.
Previous reports have failed to demonstrate a long
lasting effect of MDMA administration on learning and
memory. Thompson et al. [47] reported that prenatal ex-
posure to MDMA did not affect performance in the ra-
dial arm maze or the Morris water maze. In line with
those findings, and using the same doses and pattern of
MDMA administration, we have previously failed to ob-
serve an effect on memory in the passive avoidance test
in adult mice treated with MDMA during adolescence
[20]. However, in the present study, the execution of the
mazes was impaired by both of the MDMA doses
employed. The lowest dose (10 mg/kg) produced a slight
effect, as the total latency increased only in the easy
mazes, and not in the difficult mazes. However, animals
treated with 20 mg/kg of MDMA presented longer total
latencies in both type of mazes. Thus, complex learning
is affected by this pattern of MDMA administration. In a
recent study [48] showed that rats exposed during ado-
lescence to a combination of alcohol and MDMA exhib-
ited significant memory deficits in the radial arm maze,
although the authors did not observe a specific effect of
alcohol or MDMA when either substance was
Figure 4 Effects of intermittent ethanol and MDMA administration during adolescence on number of errors on each trail in the
Hebb-Williams maze (4a for the easy and 4b for the difficult mazes). The mazes were classified as easy (1, 3 and 4) or difficult (5 and 8).
Mice were treated with Saline (Sal), 10 or 20 mg/kg of MDMA (M10 and M20), 1.25 g/kg of ethanol (E1.25), or 1.25 g/kg of ethanol + 10 or 20 mg/
kg of MDMA (E1.25 +M10 and E1.25 +M20). Data are presented as mean values ± S.E.M. Differences with respect to first, second, third and fourth
trials * p < 0.001.
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doses administered only two times.
We have previously described the deleterious effect of
intermittent intensive EtOH ingestion during adoles-
cence on learning and memory in rats [30]. The present
findings confirm those results and, additionally, we have
observed that the effect of EtOH is independent of that
of MDMA. All the groups treated with EtOH presented
a longer total latency to achieve the goal and needed
more trials to reach the acquisition criterion score thanthose that did not receive EtOH, while the former ani-
mals did not present a reduction in latency in successive
trials, unlike the latter. It should be pointed out that the
dose of EtOH employed in the present study was smaller
(1.25 g/kg) than that used by Pascual et al. (3 g/kg) and
was chosen on the basis of other studies carried out in
our laboratory [20] in which it did not induce strong be-
havioral effects when administered alone, thus allowing
the interaction with MDMA to become apparent. Other
authors have reported that low doses of EtOH (0.5 g/kg)
Table 2 Effects of intermittent ethanol and MDMA administration during adolescence on the concentration of brain
monoamines in the striatum and hippocampus in mice
Sal M10 M20 E1.25 E1.25+M10 E1.25+M20
Striatum
DA 12364±1015 13315±981 7454±713*** 11962±1176 9471±1929*** 9850±1041***
DOPAC 1519±210 927±102 719±53++ 1082±119 1069±202 765±106++
DATurnover 0.12±0.02 0.07±0.001** 0.1±0.01 0.09±0.01* 0.11±0.01 0.08±0.001
5-HT 924±76 1110±95 825±72 1247±98+ 1128±167+ 1200±289+
5-HIIA 547±86 441±16 450±47 590±101 859±234 507±57
5-HT Turnover 0.59±0.07 0.4±0.02 0.6±0.06 0.51±0.08 0.75±0.17 0.53±0.18
Hippocampus
5–-HT 534±37 570±67 489±179 959±207+ 560±48+ 635±56+
5–-HIIA 504±85 613±111 541±65 1109±375 496±69 637±37
Animals were treated during adolescence with Saline (Sal), 10 mg/kg of MDMA (M10), 20 mg/kg of MDMA (M20), 1.25 mg/kg of ethanol (E1.25), 1.25 mg/kg of
ethanol+10 mg/kg of MDMA (E1.25+M10), or 1.25 mg/kg of ethanol+20 mg/kg of MDMA (E1.25+M20). Data are presented in means with ±S.E.M. Differences with
respect to the saline group *p< 0.05, ** p< 0.02, *** p< 0.001; differences with respect to non-EtOH treated groups + p< 0.03; differences with respect to
non-MDMA treated groups ++ p< 0.001.
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less of the age of the animal [49]. Moreover, chronic
intermittent EtOH exposure during adolescence does
not impair spatial learning when rats are trained on days
on which they are not treated with EtOH [50,51]. In a
binge paradigm, adolescent rats develop a higher toler-
ance to EtOH-induced loss of righting reflex than adults,
and this tolerance is maintained in adulthood [50,52].
For some authors, these data suggest that the acquisition
of spatial cognition in adolescent rats is resistant to
chronic intermittent EtOH administration and that the
adolescent hippocampus is not as fragile as previously
indicated [53]. In contrast, our data confirm that admin-
istration of a low dose of EtOH in a binge pattern during
adolescence induces long lasting effects on the learning
of a complex task in adult animals.
Analysis of the different treatment groups revealed
that all the animals committed fewer errors as the trial
progressed, which is proof that they learned the task.
However, latency data showed that all the groups, and
especially those treated with EtOH, required more time
than controls to reach the goal. Latencies can be affected
by some variables such as motor activity or anxiety.
Thus, to correctly interpret these data, we must take
into account that the animals treated with 20 mg/kg of
MDMA during adolescence, alone or plus EtOH, exhib-
ited higher levels of locomotor activity in adulthood
[20]. This effect led these animals to engage in more ex-
ploration of the maze and, thus, to commit more mis-
takes (especially in the first trial), although the number
of errors decreased as the trials progressed. On the other
hand, a high percentage of animals in the E.15 +M10
group (an average of 50%) exhibited immobility and did
not reach the goal in the maximum time permitted (5
minutes) in either easy or difficult mazes. As they wereless active, these animals committed fewer errors but
presented the longest latencies to reach the goal. Al-
though all the mice treated with EtOH plus MDMA dis-
played higher levels of anxiety, only those treated with
20 mg/kg also presented higher motor activity. The
longer latencies observed in the E1.25 +M10 group
could have been due, at least partially, to their elevated
level of anxiety [20], which would have made them en-
gage in less exploration behavior. On the other hand, the
mice treated with EtOH plus the highest MDMA dose,
though displaying similar levels of anxiety, were more
active and explored the maze more (and committed
more mistakes), which could have counteracted the
anxiogenic effect and enabled them to reach the goal
more quickly.
The results observed in this study could be affected by
the different neurotoxic profiles of the two MDMA
doses employed. In accordance with a previous report by
our group [20], this pattern of administration did not in-
duce neurotoxic damage when 10 mg/kg of MDMA
were administered, but a significant decrease in striatal
DA concentration was induced by 20 mg/kg, an effect
that was augmented by EtOH. Striatal DA concentration
was lower in the two groups treated with 20 mg/kg of
MDMA and in that treated with 10 mg/kg of MDMA
plus EtOH. DOPAC levels dropped in all the treatment
groups, although the decrease was significant only in
those treated with the highest dose of MDMA, which
also displayed lower DA levels. In this way, the decrease
in DA turnover occurred only in the groups treated with
EtOH or 10 mg/kg of MDMA alone, which presented
DA concentrations similar to those of the control group.
Impairment of the learning processes and alteration of
DA neurotransmission (a decrease in the metabolite
concentration or its turnover) were observed in all the
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hippocampal serotonin was observed in the EtOH-
treated groups (those which presented more affectation
of learning), thus altering the equilibrium between these
two neurotransmitters. Learning and memory depend, at
least in part, on short- or long-lasting synaptic modifica-
tions that occur mainly at dendritic spines. The modula-
tory influence of 5-HT and DA at the synaptic level may
affect the codification of mnemonic information in such
spines. Several experimental models of neurotransmitter
activity have identified a close association between an im-
balance of 5-HT-DA and cytoarchitectonic changes under-
lying learning and memory impairment [54]. Evidence
indicates that pharmacological disruption of serotonin
neurotransmission promotes the processing of mnemonic
information by cerebral regions subjected to strong DA
modulation. On the other hand, increased serotonin
neurotransmission appears to have a detrimental effect on
the cognitive functions of these structures [55].
There are few studies to have evaluated the interaction
between EtOH and a neurotoxic dose of MDMA. Expos-
ure to a neurotoxic dose of MDMA has been shown to
decrease the sedative-hypnotic effect of acute EtOH. In
MDMA-lesioned mice, EtOH did not modify striatal
GABA accumulation, suggesting that the regulation of
GABAergic neurons is less sensitive to the effects of
EtOH when a brain has been damaged by MDMA [56].
It should be taken into consideration that GABAA
receptor-mediated inhibitory tonic currents in the den-
tate gyrus of the hippocampus are more enhanced in
adolescent rats than in adults after EtOH administration
[57], which highlights the importance of the changes in
GABA function reported by Izco and coworkers (2010).
In line with this, a previous report by the same authors
showed that mice pre-exposed to a neurotoxic dose of
MDMA exhibited a higher consumption of and prefer-
ence for EtOH than saline-treated animals. These mice
also exhibited a lower level of release of basal dopamine
in the nucleus accumbens when compared with saline-
injected animals. Intraperitoneal administration of EtOH
produced an increase of extracellular dopamine release
in the nucleus accumbens of saline-treated mice, but this
effect was almost non-existent in MDMA-treated mice
[14].
The interaction between EtOH and MDMA can be
explained in different ways. The presence of EtOH
increases the availability of MDMA in the plasma and
brain of mice [15] and in the plasma of humans [58]. A
recent study in rats showed that EtOH increases delivery
of MDMA to the brain, especially in the striatum and
cortex, an effect that could increase the risk of drug
neurotoxicity [16]. Additionally, there seems to be an
additive synergism between the effects of MDMA and
EtOH on the release of monoamines, and particularlythat of dopamine and 5-HT. In this context, a local syn-
ergistic interaction of EtOH and MDMA with the
spontaneous outflow and electrically-evoked release of
striatal DA and 5-HT has been reported [59]. In this
way, when administered with a low dose of MDMA, the
EtOH present in several brain areas can increase, thus
enhancing the behavioral effects observed.
The use in animal studies of much higher doses and
different routes of administration to those of recreational
human use raises the question of whether animal data
reflect ‘heavy’ use of MDMA [60]. A recreational user
can be defined as ‘a person who ingests a standard dose
(80–150 mg) of MDMA’ occasionally [61,62]. When
extrapolated to humans, the doses and pattern of
MDMA administration employed in this study represent
a higher intake of ecstasy, but the marked metabolic dif-
ferences between rodents and humans should also be
taken into consideration [63]. Mice have a more rapid
and efficient metabolism than humans and are not
thought to possess an auto-inhibition of the metabolism
of MDMA. Bearing in mind these differences, we chose
a consecutive pattern of MDMA administration, since
we calculated that 4 doses would induce lower levels of
the drug in mice than in humans. In addition, we admi-
nistered a moderate dose of EtOH. Therefore, our model
mimics the pattern of use of adolescents who take a
moderate or high (in case of 20 mg/kg) number of
MDMA pills with 2 or 3 alcoholic drinks. The use of a
mouse model to study the effects of MDMA has certain
aspects that must be taken into consideration. This
model is a useful tool to isolate the consequences of
dopaminergic neurotoxicity, which is of great interest in
light of the high number of MDMA consumers who also
take methamphetamine. In general, studies of MDMA
performed in animal models, especially those which
focus on its neurotoxic effects, provoke serious con-
cerns, regardless of the species employed. Most rodent
studies employ an acute regimen of high doses of
MDMA in order to induce neurotoxicity, whereas
humans tend to extend their use over weeks. In addition,
the dose of MDMA employed may exceed the normal
dosage of human abuse. It is clearly difficult to directly
compare the dosages that cause neurotoxicity in rodents
and humans respectively; in addition to metabolic differ-
ences, poly-drug use and environmental stimuli can
modulate the pharmacological effects of the drug in
humans but not in rodents, which are maintained in a
controlled laboratory environment. All of these factors
make it impossible to directly extrapolate any finding
from rodent studies to humans.
Conclusions
The risks associated with multi-drug exposure during
adolescence are still to be clarified. However, it is clear
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damaging effects of EtOH and that these effects are usu-
ally irreversible (for a review, see Guerri, 2002). Our study
has confirmed this vulnerability and reveals that mice
treated during adolescence with a binge pattern of EtOH,
MDMA or both drugs together exhibit impaired learning
and memory in both easy and difficult Hebb-Williams
mazes in adulthood. Although this effect was independent
of the MDMA-induced decrease in striatal DA concentra-
tion, all the affected groups displayed an imbalance in the
DA/serotonin interaction.
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